The size of the Europe bioabsorbable stents market is estimated to worth USD 1627.02 million by 2026 from USD 286.82 million in 2021 at a CAGR of 41.5% from 2021 to 2026.
Stents can be generally used as a part of the treatment of blocked arteries. They are small and expandable work tubes that hold arteries open and help treat coronary and peripheral artery diseases. Bioabsorbable stents are called as completely biodegradable stents that totally disappear over time.
A stent is a metallic or a polymer tube inserted into the lumen of any vein or a channel in order to keep the section open. Various stents for different clinical conditions are available in the market. A stent insert is most regularly used for the treatment of cardiovascular variations from the norm, for instance, blocked veins. Stents are implanted in the throat to allow the section of food and beverages in patients to encounter esophageal diseases. They can likewise be utilized as a part of kidneys, stomach and gastrointestinal tract for different purposes. Utilizing of bioabsorbable stents rather than permanent metallic stents takes out the need to experience second surgery to evacuate the metallic stents.
Increment in cardiovascular surgeries is because of the increase in the risk of cardiovascular issues among the general population experiencing weight. According to WHO reports, cardiovascular issues are the primary source of death than some other medical problems, it is normal that by 2030 more than 23 million people suffer from Cardiovascular infections. In this way, the Aging population and increment in the cardiovascular diseases are the Key driving variables for the development of the European bioabsorbable stents market. Positive results of surgeries with bioabsorbable stents and post-surgery reports additionally represent the advancement of the market. In any case, there are numerous administrative, innovative, safety-viability and furthermore cost-related issues that should be managed before achieving its maximum capacity.
This research report on the European bioabsorbable Stents Market has been segmented and sub-segmented into the following categories.
By Material:
By Absorption Rate:
By Application:
By End User:
By Country:
Key market participants leading the Europe Bioabsorbable stents market are Elixir Medical Corporation, Arterius Limited, Amaranth Medical Inc, Abbott Laboratories, Arterial Remodeling Technologies S.A, Biotronik, Kyoto Medical Planning Co Ltd., Reva Medical Inc, Tepha.Inc, SMT, Xenogenics Corporation.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Material
5.1.1 Introduction
5.1.2 Polymer stents
5.1.3 Metallic stents
5.1.4 Y-o-Y Growth Analysis, By Material
5.1.5 Market Attractiveness Analysis, By Material
5.1.6 Market Share Analysis, By Material
5.2 Absorption
5.2.1 Introduction
5.2.2 Slow absorption stents
5.2.3 High absorption stents
5.2.4 Y-o-Y Growth Analysis, By absorption
5.2.5 Market Attractiveness Analysis, By absorption
5.2.6 Market Share Analysis, By absorption
5.3 Application
5.3.1 Introduction
5.3.2 coronary artery disease
5.3.3 peripheral artery disease
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
5.4 End User
5.4.1 Introduction
5.4.2 Hospitals
5.4.3 Cardiac centers
5.4.7 Y-o-Y Growth Analysis, By End User
5.4.8 Market Attractiveness Analysis, By End User
5.4.9 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Material
6.1.3.3 By absorption
6.1.3.4 By Application
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Material
6.1.4.3 By absorption
6.1.4.4 By Application
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Material
6.1.5.3 By Absorption
6.1.5.4 By Application
6.1.5.5 By End User
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Elixir Medical Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Arterius Limited
8.3 Amaranth Medical Inc
8.4 Abbott Laboratories
8.5 Arterial Remodeling Technologies S.A
8.6 Biotronik
8.7 Kyoto Medical Planning Co Ltd
8.8 Reva Medical Inc
8.9 Tepha.Inc
8.10 Xenogenics Corporation
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Europe bioabsorbable Stents Market
Related Reports
